{
  "ticker": "UPB",
  "company_name": "Upstream Bio, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06196879",
      "title": "A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Severe Asthma",
      "start_date": "2024-02-27",
      "completion_date": "2026-06-11",
      "enrollment": 0,
      "sponsor": "Upstream Bio Inc."
    },
    {
      "nct_id": "NCT06981078",
      "title": "A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Chronic Obstructive Pulmonary Disease",
      "start_date": "2025-07-02",
      "completion_date": "2028-07",
      "enrollment": 0,
      "sponsor": "Upstream Bio Inc."
    },
    {
      "nct_id": "NCT05653479",
      "title": "Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2022-12-05",
      "completion_date": "2023-05-13",
      "enrollment": 0,
      "sponsor": "Upstream Bio Inc."
    },
    {
      "nct_id": "NCT05448651",
      "title": "Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Asthma",
      "start_date": "2022-07-08",
      "completion_date": "2023-10-05",
      "enrollment": 0,
      "sponsor": "Upstream Bio Inc."
    },
    {
      "nct_id": "NCT06966479",
      "title": "A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Severe Asthma",
      "start_date": "2025-05-21",
      "completion_date": "2027-09",
      "enrollment": 0,
      "sponsor": "Upstream Bio Inc."
    },
    {
      "nct_id": "NCT06164704",
      "title": "A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Chronic Rhinosinusitis With Nasal Polyps",
      "start_date": "2023-12-18",
      "completion_date": "2025-07-22",
      "enrollment": 0,
      "sponsor": "Upstream Bio Inc."
    }
  ],
  "summary": {
    "total_trials": 6,
    "by_phase": {
      "PHASE2": 4,
      "PHASE1": 2
    },
    "by_status": {
      "ACTIVE_NOT_RECRUITING": 1,
      "RECRUITING": 2,
      "COMPLETED": 3
    },
    "active_trials": 3,
    "completed_trials": 3,
    "conditions": [
      "Asthma",
      "Chronic Obstructive Pulmonary Disease",
      "Chronic Rhinosinusitis With Nasal Polyps",
      "Healthy",
      "Severe Asthma"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:22:38.876404",
    "search_query": "Upstream Bio, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Upstream+Bio,+Inc."
  }
}